Medtronic SynchroMed Flex Infusion Mode Clinician Programmer Software Recall
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Medtronic Neuromodulation is recalling 10,165 units of SynchroMed Flex Infusion Mode A810 Clinician Programmer Software loaded on CT900 series tablets worldwide due to a software issue that may display infusion steps out of order.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on June 2, 2026 and geographically references Worldwide. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, devices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Medtronic Neuromodulation initiated a voluntary Class II recall of the Medtronic SynchroMed Flex Infusion Mode - A810 Clinician Programmer Software Application. The software issue occurs when programming the SynchroMed Pump with the A810 CP App in Flex Infusion Mode: infusion steps should automatically arrange in consecutive order from earliest to latest, but in rare cases the steps may be displayed out of order. If this occurs, the programmed Flex Infusion schedule will not be delivered at the intended time, if at all. The recall is ongoing with worldwide distribution.
Which Products Are Affected
The recall affects the Medtronic SynchroMed Flex Infusion Mode - A810 Clinician Programmer Software Application (software versions 1.x and 2.x) loaded on the following devices:
- PROG CT900A CLINICIAN TABLET US (Model CT900A, GTIN 00643169890923)
- PROG CT900B CLINICIAN TABLET EU -UK (Model CT900B, GTIN 00643169890947)
- PROG CT900C CLINICIAN TABLET UK (Model CT900C, GTIN 00643169890961)
- PROG CT900D CLINICIAN TABLET GLOBAL (Model CT900D, GTINs 00763000077730, 00763000094027, 00763000421007)
- PROG CT900E CLINICIAN TABLET GLBL SMSNG (Model CT900E, GTINs 00763000447090, 00763000729141, 00763000737290)
- PROG CT900F CLINICIAN TABLET GLBL SMSNG (Model CT900F, GTINs 00763000926144, 00763000984649) A total of 10,165 units are affected, identified by numerous specific serial numbers listed in FDA recall Z-2201-2026. The recalling firm is Medtronic Neuromodulation, Minneapolis, MN.
What You Should Do
The recall was initiated voluntarily by the firm with initial notification via email, fax, letter, press release, telephone, or visit. Consumers with affected devices should refer to the FDA recall notice for further instructions.
Why This Matters
The software defect could result in the SynchroMed infusion pump not delivering medication according to the intended Flex Infusion schedule.
Source
FDA Enforcement Report, recall number Z-2201-2026, event ID 98750 (https://www.fda.gov/safety/recalls)
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category